We are live on ! Find out more
ODT

Odonate Therapeutics, Inc. Common Stock
ODT

Delisted

ODT was delisted on the 14th of January, 2022.

Back to rankings

26 hedge funds and large institutions have $541M invested in Odonate Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.59%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.09%
New
26
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$288M
2
BC
Boxer Capital
California
+$64.4M
3
Franklin Resources
Franklin Resources
California
+$37.3M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$20.1M
5
SM
Sabby Management
Florida
+$19.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tang Capital Management
California
$305M +$288M +12,202,338 New
BC
2
Boxer Capital
California
$68.2M +$64.4M +2,726,938 New
Franklin Resources
3
Franklin Resources
California
$38.4M +$37.3M +1,577,927 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$21.3M +$20.1M +850,000 New
SM
5
Sabby Management
Florida
$20.6M +$19.5M +825,451 New
RG
6
Redmile Group
California
$14.9M +$14.1M +596,900 New
SAAM
7
Solus Alternative Asset Management
New Jersey
$11.8M +$11.1M +471,616 New
Invesco
8
Invesco
Georgia
$10.4M +$9.84M +416,667 New
RSCM
9
Rock Springs Capital Management
Maryland
$10.3M +$9.69M +410,000 New
RI
10
RTW Investments
New York
$6.77M +$7.03M +297,555 New
Allianz Asset Management
11
Allianz Asset Management
Germany
$6.09M +$5.75M +243,535 New
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
$4.76M +$4.49M +190,229 New
PA
13
Perceptive Advisors
New York
$3.75M +$3.54M +150,000 New
Ameriprise
14
Ameriprise
Minnesota
$3.5M +$3.3M +139,756 New
MIM
15
Monashee Investment Management
Massachusetts
$3.13M – – –
Victory Capital Management
16
Victory Capital Management
Texas
$2.61M +$2.47M +104,450 New
Millennium Management
17
Millennium Management
New York
$2.28M +$2.15M +91,093 New
Vanguard Group
18
Vanguard Group
Pennsylvania
$1.51M +$1.43M +60,430 New
Norges Bank
19
Norges Bank
Norway
$1.25M +$1.18M +50,000 New
SCM
20
Sio Capital Management
New York
$1.25M +$1.18M +50,000 New
Mirae Asset Global Investments
21
Mirae Asset Global Investments
South Korea
$878K +$829K +35,100 New
CIP
22
Chartwell Investment Partners
Pennsylvania
$755K +$714K +30,218 New
Goldman Sachs
23
Goldman Sachs
New York
$660K +$623K +26,380 New
MWNA
24
Marshall Wace North America
New York
$472K +$446K +18,897 New
Morgan Stanley
25
Morgan Stanley
New York
$88K +$83.1K +3,518 New
1
2

ODT Hedge Fund Activity: Q4 2017 in Review

26 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q4 2017, worth a combined $541M.

Buyers outnumbered sellers: 26 funds opened new ODT positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $288M.

  • 26 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $541M of Odonate Therapeutics, Inc. Common Stock stock for Q4 2017.
  • 26 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q4 2017 and 0 closed out, a net change of +26 holders.
  • The largest Odonate Therapeutics, Inc. Common Stock buyer in Q4 2017 was Tang Capital Management, an estimated $288M added.

Based on aggregated 13F filings for Q4 2017.